BILLERICA, Mass. and SCHIEDAM, The Netherlands--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL) and Applikon Biotechnology B.V. today announced an agreement to co-develop and distribute disposable bioreactor systems for biopharmaceutical applications. The agreement will build upon the leading positions of Millipore in the disposables market and Applikon in the bioreactor systems market which will facilitate their joint entry into the disposable bioreactor segment of the market.